S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.85 (+2.26%)
NVDA   249.28 (+0.14%)
BABA   227.50 (+1.59%)
MU   57.66 (-0.03%)
AMD   50.93 (+2.33%)
F   9.15 (-0.22%)
DIS   144.25 (-0.60%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.85 (+2.26%)
NVDA   249.28 (+0.14%)
BABA   227.50 (+1.59%)
MU   57.66 (-0.03%)
AMD   50.93 (+2.33%)
F   9.15 (-0.22%)
DIS   144.25 (-0.60%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.85 (+2.26%)
NVDA   249.28 (+0.14%)
BABA   227.50 (+1.59%)
MU   57.66 (-0.03%)
AMD   50.93 (+2.33%)
F   9.15 (-0.22%)
DIS   144.25 (-0.60%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.85 (+2.26%)
NVDA   249.28 (+0.14%)
BABA   227.50 (+1.59%)
MU   57.66 (-0.03%)
AMD   50.93 (+2.33%)
F   9.15 (-0.22%)
DIS   144.25 (-0.60%)
Log in

NYSE:MED - Medifast Stock Price, Forecast & News

$115.66
-1.23 (-1.05 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$114.14
Now: $115.66
$117.25
50-Day Range
$85.64
MA: $101.49
$116.89
52-Week Range
$66.50
Now: $115.66
$159.41
Volume13,120 shs
Average Volume235,436 shs
Market Capitalization$1.34 billion
P/E Ratio25.03
Dividend Yield3.92%
Beta0.73
Medifast, Inc, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. Read More…

Industry, Sector and Symbol

Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products
SectorConsumer Staples
CUSIP58470H10
Phone410-581-8042

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$501 million
Cash Flow$5.04 per share
Book Value$9.12 per share

Profitability

Net Income$55.79 million

Miscellaneous

Employees420
Market Cap$1.34 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableOptionable

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.


#1 Futurist Says: Get Ready for This Global "Reboot" (Ad)


George Gilder has a shocking message for anybody with money in the bank, with a job that pays in dollars, or who carries a smartphone in their pocket. "Brace yourself," he says, "for the coming $16.8 trillion global 'reboot' ahead." It could change the way you get paid...change the way you save and invest for retirement.

Medifast (NYSE:MED) Frequently Asked Questions

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Thursday, December 5th. Stockholders of record on Friday, December 27th will be given a dividend of $1.13 per share on Thursday, February 6th. This represents a $4.52 annualized dividend and a dividend yield of 3.91%. The ex-dividend date is Thursday, December 26th. This is an increase from Medifast's previous quarterly dividend of $0.75. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) issued its earnings results on Thursday, November, 7th. The specialty retailer reported $1.32 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $1.33 by $0.01. The specialty retailer had revenue of $190.10 million for the quarter, compared to analyst estimates of $194.70 million. Medifast had a net margin of 10.70% and a return on equity of 62.93%. The firm's revenue for the quarter was up 36.5% on a year-over-year basis. During the same period in the previous year, the business posted $1.14 earnings per share. View Medifast's Earnings History.

When is Medifast's next earnings date?

Medifast is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Medifast.

What guidance has Medifast issued on next quarter's earnings?

Medifast issued an update on its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided EPS guidance of $5.80-5.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.83. The company issued revenue guidance of $$700-710 million, compared to the consensus revenue estimate of $$750.45 million.

What price target have analysts set for MED?

4 equities research analysts have issued 12 month price objectives for Medifast's shares. Their forecasts range from $74.00 to $216.00. On average, they anticipate Medifast's stock price to reach $140.00 in the next twelve months. This suggests a possible upside of 21.0% from the stock's current price. View Analyst Price Targets for Medifast.

What is the consensus analysts' recommendation for Medifast?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medifast.

Has Medifast been receiving favorable news coverage?

News coverage about MED stock has been trending somewhat positive recently, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Medifast earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned news headlines about the specialty retailer a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Medifast.

Are investors shorting Medifast?

Medifast saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 4,110,000 shares, a drop of 8.9% from the December 15th total of 4,510,000 shares. Based on an average daily trading volume, of 408,800 shares, the short-interest ratio is presently 10.1 days. Approximately 36.7% of the company's shares are sold short. View Medifast's Current Options Chain.

Who are some of Medifast's key competitors?

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Paypal (PYPL), Home Depot (HD), Adobe (ADBE), Mastercard (MA), Boeing (BA), Lululemon Athletica (LULU) and Baidu (BIDU).

Who are Medifast's key executives?

Medifast's management team includes the folowing people:
  • Mr. Daniel R. Chard, CEO & Director (Age 54)
  • Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 57)
  • Mr. William Baker IV, Exec. VP of Information Technology (Age 47)
  • Mr. Nicholas Johnson, Exec. VP of Coach Success Market Pres of OPTAVIA USA (Age 39)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 48)

Who are Medifast's major shareholders?

Medifast's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Ingalls & Snyder LLC (0.54%), Winmill & CO. Inc. (0.34%), Chickasaw Capital Management LLC (0.28%), State of Alaska Department of Revenue (0.08%), Nisa Investment Advisors LLC (0.04%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Medifast stock include Carl E Sassano, Charles P Connolly, Constance J Hallquist, Daniel R Chard, Michael A Hoer, Michael C Macdonald and Scott Schlackman. View Institutional Ownership Trends for Medifast.

Which major investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including Chickasaw Capital Management LLC, Louisiana State Employees Retirement System and State of Alaska Department of Revenue. Company insiders that have sold Medifast company stock in the last year include Carl E Sassano and Scott Schlackman. View Insider Buying and Selling for Medifast.

Which major investors are buying Medifast stock?

MED stock was acquired by a variety of institutional investors in the last quarter, including Winmill & CO. Inc., Ingalls & Snyder LLC, Nisa Investment Advisors LLC and FormulaFolio Investments LLC. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard and Michael A Hoer. View Insider Buying and Selling for Medifast.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $115.66.

How big of a company is Medifast?

Medifast has a market capitalization of $1.34 billion and generates $501 million in revenue each year. The specialty retailer earns $55.79 million in net income (profit) each year or $4.62 on an earnings per share basis. Medifast employs 420 workers across the globe.View Additional Information About Medifast.

What is Medifast's official website?

The official website for Medifast is http://www.medifast1.com/.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]


MarketBeat Community Rating for Medifast (NYSE MED)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  329 (Vote Outperform)
Underperform Votes:  339 (Vote Underperform)
Total Votes:  668
MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel